FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2203122092> ?p ?o ?g. }

• W2203122092 endingPage "160" @default.
• W2203122092 startingPage "150" @default.
• W2203122092 abstract "1.We investigated dyslipidemia in the top-ranked hospitals with relatively sufficient medical resources in China. 2.The prevalence of dyslipidemia is high and the awareness, treatment, and control of dyslipidemia are relatively low in Chinese T2DM patients 3.The situation of comprehensive management in T2DM is beyond optimism in China. Objective The aim of this study was to assess the levels of serum lipid and awareness, treatment, and control of dyslipidemia in type 2 diabetes mellitus (T2DM) patients from top-ranked endocrinology clinics in large cities of China. Materials and Methods A cross-sectional study in a representative sample of 4807 Chinese adults 40 to 75 years of age was conducted during 2010 to 2011 at 20 endocrinology clinics in top-ranked hospitals covering most of the major cities of China. Serum lipid levels were measured, and treatment of dyslipidemia was recorded and assessed. Results In the present study, the prevalence of dyslipidemia was 67.1% in T2DM subjects. Among those with dyslipidemia, the proportion of awareness and treatment was 68.7% and 55.9%. Among participants with lipid-lowering therapy, 686 subjects achieved the low-density lipoprotein cholesterol (LDL-C) control less than 2.60 mmol/L, with the rate being 39.4%. In those patients with previous cardiovascular disease, the percentage of participants who achieved LDL-C goal (1.80 mmol/L) was 15.3%. Conclusion The prevalence of dyslipidemia is high, and the awareness, treatment, and control of dyslipidemia are relatively low in Chinese T2DM patients. This calls for the awareness and intervention of dyslipidemia in these patients. The aim of this study was to assess the levels of serum lipid and awareness, treatment, and control of dyslipidemia in type 2 diabetes mellitus (T2DM) patients from top-ranked endocrinology clinics in large cities of China. A cross-sectional study in a representative sample of 4807 Chinese adults 40 to 75 years of age was conducted during 2010 to 2011 at 20 endocrinology clinics in top-ranked hospitals covering most of the major cities of China. Serum lipid levels were measured, and treatment of dyslipidemia was recorded and assessed. In the present study, the prevalence of dyslipidemia was 67.1% in T2DM subjects. Among those with dyslipidemia, the proportion of awareness and treatment was 68.7% and 55.9%. Among participants with lipid-lowering therapy, 686 subjects achieved the low-density lipoprotein cholesterol (LDL-C) control less than 2.60 mmol/L, with the rate being 39.4%. In those patients with previous cardiovascular disease, the percentage of participants who achieved LDL-C goal (1.80 mmol/L) was 15.3%. The prevalence of dyslipidemia is high, and the awareness, treatment, and control of dyslipidemia are relatively low in Chinese T2DM patients. This calls for the awareness and intervention of dyslipidemia in these patients." @default.
• W2203122092 created "2016-06-24" @default.
• W2203122092 creator A5001288918 @default.
• W2203122092 creator A5003520375 @default.
• W2203122092 creator A5010379347 @default.
• W2203122092 creator A5016045178 @default.
• W2203122092 creator A5018266443 @default.
• W2203122092 creator A5025324574 @default.
• W2203122092 creator A5028228964 @default.
• W2203122092 creator A5035709948 @default.
• W2203122092 creator A5051432835 @default.
• W2203122092 creator A5051992470 @default.
• W2203122092 creator A5053192318 @default.
• W2203122092 creator A5054565575 @default.
• W2203122092 creator A5061487364 @default.
• W2203122092 creator A5064671323 @default.
• W2203122092 creator A5065359330 @default.
• W2203122092 creator A5065796571 @default.
• W2203122092 creator A5069611208 @default.
• W2203122092 creator A5069771802 @default.
• W2203122092 creator A5072920878 @default.
• W2203122092 creator A5073846087 @default.
• W2203122092 creator A5074127060 @default.
• W2203122092 creator A5077604881 @default.
• W2203122092 creator A5088692433 @default.
• W2203122092 date "2016-01-01" @default.
• W2203122092 modified "2023-10-13" @default.
• W2203122092 title "Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China" @default.
• W2203122092 cites W1601241121 @default.
• W2203122092 cites W1922625321 @default.
• W2203122092 cites W1965344989 @default.
• W2203122092 cites W1972661406 @default.
• W2203122092 cites W1996612805 @default.
• W2203122092 cites W1999826488 @default.
• W2203122092 cites W2003771230 @default.
• W2203122092 cites W2023590870 @default.
• W2203122092 cites W2075557567 @default.
• W2203122092 cites W2080650607 @default.
• W2203122092 cites W2107295258 @default.
• W2203122092 cites W2108998797 @default.
• W2203122092 cites W2114888422 @default.
• W2203122092 cites W2127850526 @default.
• W2203122092 cites W2130266732 @default.
• W2203122092 cites W2134293572 @default.
• W2203122092 cites W2137808916 @default.
• W2203122092 cites W2146514310 @default.
• W2203122092 cites W2157453590 @default.
• W2203122092 cites W2162078466 @default.
• W2203122092 cites W2171440185 @default.
• W2203122092 cites W2320667240 @default.
• W2203122092 cites W2587018809 @default.
• W2203122092 doi "https://doi.org/10.1016/j.jacl.2015.10.009" @default.
• W2203122092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26892132" @default.
• W2203122092 hasPublicationYear "2016" @default.
• W2203122092 type Work @default.
• W2203122092 sameAs 2203122092 @default.
• W2203122092 citedByCount "57" @default.
• W2203122092 countsByYear W22031220922016 @default.
• W2203122092 countsByYear W22031220922017 @default.
• W2203122092 countsByYear W22031220922018 @default.
• W2203122092 countsByYear W22031220922019 @default.
• W2203122092 countsByYear W22031220922020 @default.
• W2203122092 countsByYear W22031220922021 @default.
• W2203122092 countsByYear W22031220922022 @default.
• W2203122092 countsByYear W22031220922023 @default.
• W2203122092 crossrefType "journal-article" @default.
• W2203122092 hasAuthorship W2203122092A5001288918 @default.
• W2203122092 hasAuthorship W2203122092A5003520375 @default.
• W2203122092 hasAuthorship W2203122092A5010379347 @default.
• W2203122092 hasAuthorship W2203122092A5016045178 @default.
• W2203122092 hasAuthorship W2203122092A5018266443 @default.
• W2203122092 hasAuthorship W2203122092A5025324574 @default.
• W2203122092 hasAuthorship W2203122092A5028228964 @default.
• W2203122092 hasAuthorship W2203122092A5035709948 @default.
• W2203122092 hasAuthorship W2203122092A5051432835 @default.
• W2203122092 hasAuthorship W2203122092A5051992470 @default.
• W2203122092 hasAuthorship W2203122092A5053192318 @default.
• W2203122092 hasAuthorship W2203122092A5054565575 @default.
• W2203122092 hasAuthorship W2203122092A5061487364 @default.
• W2203122092 hasAuthorship W2203122092A5064671323 @default.
• W2203122092 hasAuthorship W2203122092A5065359330 @default.
• W2203122092 hasAuthorship W2203122092A5065796571 @default.
• W2203122092 hasAuthorship W2203122092A5069611208 @default.
• W2203122092 hasAuthorship W2203122092A5069771802 @default.
• W2203122092 hasAuthorship W2203122092A5072920878 @default.
• W2203122092 hasAuthorship W2203122092A5073846087 @default.
• W2203122092 hasAuthorship W2203122092A5074127060 @default.
• W2203122092 hasAuthorship W2203122092A5077604881 @default.
• W2203122092 hasAuthorship W2203122092A5088692433 @default.
• W2203122092 hasConcept C126322002 @default.
• W2203122092 hasConcept C134018914 @default.
• W2203122092 hasConcept C17744445 @default.
• W2203122092 hasConcept C191935318 @default.
• W2203122092 hasConcept C199539241 @default.
• W2203122092 hasConcept C2778096610 @default.
• W2203122092 hasConcept C2778163477 @default.
• W2203122092 hasConcept C2778270857 @default.
• W2203122092 hasConcept C2779134260 @default.

• next